SIGA Technologies Inc. (SIGA)
5.98
0.37 (6.60%)
At close: Mar 24, 2025, 3:59 PM
5.98
0.00%
After-hours: Mar 24, 2025, 05:13 PM EDT
6.60% (1D)
| Bid | 5.97 |
| Market Cap | 427.19M |
| Revenue (ttm) | 139.08M |
| Net Income (ttm) | 59.37M |
| EPS (ttm) | 0.82 |
| PE Ratio (ttm) | 7.29 |
| Forward PE | 4.91 |
| Analyst | n/a |
| Ask | 6.04 |
| Volume | 304,339 |
| Avg. Volume (20D) | 433,460 |
| Open | 5.72 |
| Previous Close | 5.61 |
| Day's Range | 5.72 - 6.03 |
| 52-Week Range | 5.16 - 12.83 |
| Beta | 0.98 |
About SIGA
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothre...
Sector Healthcare
IPO Date Sep 10, 1997
Employees 46
Stock Exchange NASDAQ
Ticker Symbol SIGA
Website https://www.siga.com
2 months ago
+3.83%
SIGA Technologies shares are trading higher after ...
Unlock content with
Pro Subscription
3 months ago
-6.77%
SIGA Technologies shares are trading lower after interim results from the STOMP study showed that Tecovirimat did not improve the time to lesion resolution compared to placebo in adults with mild to moderate clade II Mpox.
